Search - tctmd.com

Displaying 281 - 300 of 1337

Sort: Relevancy | Date

Presentation TCT 2023

TCT 353: SAvvyWire™ Efficacy and Safety in Transcatheter Aortic Valve Implantation Procedures Trial

Presenter: Ander Regueiro

October 25, 2023

Presentation TCT 2023

Screen Failures, Technology Woes, Lack of Clinical Evidence, and Difficult Clinical Trial Pathways – TMVR is No More than a Niche!

Presenter: Isaac George

October 25, 2023

Presentation TCT 2023

TWIST Pipeline

Presenter: NULL

October 25, 2023

Presentation TCT 2023

How it Started… How it’s Going. CONFORMAL EFS Clinical Data & CONFORM Trial Update

Presenter: William Gray

October 25, 2023

Presentation TCT 2023

LV positive reverse remodeling in the TWIST study

Presenter: Ehud Schwammenthal

October 25, 2023

Presentation TCT 2023

TWIST study clinical data

Presenter: Samir Kapadia

October 25, 2023

Presentation TCT 2023

TWIST Live case

Presenter: Chet Rihal

October 25, 2023

Presentation TCT 2023

TWIST TMVR technology overview

Presenter: Ehud Raanani

October 25, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

Presentation TCT 2023

The Future of Transcatheter Therapies for AR: The Impact of the ALIGN-AR Trial

Presenter: Martin Leon

October 24, 2023

Presentation TCT 2023

Valve Hemodynamics and Device Performance: A New Era in Safety and Technical Success for TAVR in AR

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2023

Diving Deep into Pacemakers: Role of Oversizing, Implant Depth and Other Considerations from the CT Core Lab

Presenter: Omar Khalique

October 24, 2023

Presentation TCT 2023

From Diagnostic Challenges in Echocardiographic Assessment of AR to Evidence of LV Remodeling: Lessons from the Echo Core Lab

Presenter: Nadira Hamid

October 24, 2023

Presentation TCT 2023

Importance of Patient Reported Outcomes

Presenter: David Cohen

October 24, 2023

Presentation TCT 2023

An Echo Deep Dive of the PARTNER 5-Year Study

Presenter: Philippe Pibarot

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2023

Perspectives on Mortality in the PARNTER 5-Year Study

Presenter: Vinod Thourani

October 24, 2023

Presentation TCT 2023

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

Presenter: Roberto Galea

October 24, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

Advertisement

TCT 353: SAvvyWire™ Efficacy and Safety in Transcatheter Aortic Valve Implantation Procedures Trial

Screen Failures, Technology Woes, Lack of Clinical Evidence, and Difficult Clinical Trial Pathways – TMVR is No More than a Niche!

TWIST Pipeline

How it Started… How it’s Going. CONFORMAL EFS Clinical Data & CONFORM Trial Update

LV positive reverse remodeling in the TWIST study

TWIST study clinical data

TWIST Live case

TWIST TMVR technology overview

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

The Future of Transcatheter Therapies for AR: The Impact of the ALIGN-AR Trial

Valve Hemodynamics and Device Performance: A New Era in Safety and Technical Success for TAVR in AR

Diving Deep into Pacemakers: Role of Oversizing, Implant Depth and Other Considerations from the CT Core Lab

From Diagnostic Challenges in Echocardiographic Assessment of AR to Evidence of LV Remodeling: Lessons from the Echo Core Lab

Importance of Patient Reported Outcomes

An Echo Deep Dive of the PARTNER 5-Year Study

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

Perspectives on Mortality in the PARNTER 5-Year Study

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content